Further on, all three GPBAR1 ligands were effective in inducing the expression of ITGB3 [34], a integrin beta-chain subunit coded by a serotonin-related gene on chromosome 17, that has been reported to be associated with the risk of several human cancers, including colorectal cancer. The gene discussed is ITGB3; the disease is colorectal cancer.